EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSDCDG00000006017
Gene Symbol: DHCR24
3 Cross references
209 Possible Orthologues:

26s Proteasome Complex Subunit Sem1

Ensembl ID : ENSDCDG00000029491
Gene Symbol: LOC114770435
3 Cross references
155 Possible Orthologues:

26s Proteasome Complex Subunit Sem1

Ensembl ID : ENSDCDG00000029499
Gene Symbol: LOC114770445
3 Cross references
155 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 4

Ensembl ID : ENSDCDG00000027909
Gene Symbol: LOC114770260
3 Cross references
228 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 4-Like

Ensembl ID : ENSDCDG00000017334
Gene Symbol: LOC114788345
3 Cross references
221 Possible Orthologues:

26s Proteasome Regulatory Subunit 10b-Like

Ensembl ID : ENSDCDG00000011284
Gene Symbol: LOC114775934
2 Cross references
223 Possible Orthologues:

26s Proteasome Regulatory Subunit 4

Ensembl ID : ENSDCDG00000004657
Gene Symbol: LOC114763414
3 Cross references
239 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSDCDG00000002494
Gene Symbol: HMGCR
3 Cross references
154 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase-Like

Ensembl ID : ENSDCDG00000027394
Gene Symbol: LOC114786602
3 Cross references
206 Possible Orthologues:

3-Oxo-5-Alpha-Steroid 4-Dehydrogenase 2-Like

Ensembl ID : ENSDCDG00000026370
Gene Symbol: LOC114795886
3 Cross references
192 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSDCDG00000033529
Gene Symbol: PDPK1
3 Cross references
222 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase-Like

Ensembl ID : ENSDCDG00000011702
Gene Symbol: LOC114800109
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).